C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) A61K 48/00 (2006.01) C07H 21/04 (2006.01) C12N 15/00 (2006.01) C12N 15/11 (2006.01) C12N 15/85 (2006.01) C12N 15/86 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2332699
The invention features antisense oligonucleotide molecules that specifically bind polynucleotides encoding IL-15. The present invention provides antisense oligonucleotides capable of inhibiting IL-15 expression, and methods of use thereof to reduce activity of IL-15 in tissues in order to treat diseases such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, chronic liver disease, ulcerative colitis and cell proliferative disorders.
Cette invention se rapporte à des molécules d'oligonucléotides anti-sens qui se fixent spécifiquement aux polynucléotides codant l'interleukine-15 (IL-15). Cette invention présente des oligonucléotides anti-sens capables d'inhiber l'expression de l'IL-15, ainsi que des procédés d'utilisation de ces oligonucléotides pour réduire l'activité de l'IL-15 dans les tissus, afin de pouvoir traiter les maladies telles que l'arthrite rhumatoïde, la maladie intestinale inflammatoire, la sclérose en plaques, les atteintes hépatiques aiguës, la colite ulcéreuse et les troubles de prolifération cellulaire.
Hamanaka Shoji
Hiroyuki Kubo
Nozawa Iwao
Veerapanane Dange
Hisamitsu Pharmaceutical Co. Inc.
Smart & Biggar
LandOfFree
Antisense oligonucleotides targeted to il-15 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense oligonucleotides targeted to il-15, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotides targeted to il-15 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1694522